Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab

Katherine Van Loon, Anne M. Espinoza, David R. Fogelman, Robert A. Wolff, Milind M. Javle, Renuka V. Iyer, Vincent J. Picozzi, Ludmila Katherine Martin, Tanios Bekaii-Saab, Margaret A. Tempero, Nathan R. Foster, George P. Kim, Andrew H. Ko

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences